Healthcare >> CEO Interviews >> May 3, 2004
DONALD R. KIEPERT JR. has served since 1997 as Chairman of the Board,
President and Chief Executive Officer of Point Therapeutics, Inc., a
Boston-based publicly traded biopharmaceutical company. He also serves
as Chairman of the Board of Pericor Sciences, Celadon Science and
Sunalert Inc. From 1989 to 1996 he was President and Chief Executive
Officer of Chartwell Home Therapies, a national home infusion services
company. Mr. Kiepert has also started and managed several healthcare
companies and worked in various management positions at Baxter Travenol,
Inc. In addition to his numerous business interests, he is a member of
the Board of Governors of Nashawtuc Country Club and a member of the
Board of Visitors for the Walnut Hill Performing Arts School. Mr.
Kiepert received a BS in Pharmacy and an MS in Clinical Pharmacy from
Purdue University. Profile
Therapeutics over the past year or so?
Mr. Kiepert: Over the last 12 months there have been a lot of key
milestones achieved. In
